So-called digital biomarkers could change the way healthcare providers and payers offer treatment and insurance to patients, according to a new report from top healthcare venture capital fund, Rock Health. The technology would allow insurers to incentivise their offerings, and design their policies around the data they receive. “Digital health is going to be an important part of how we deliver care in the future,” said Dr. David Cohen, CEO of Rock Health, which has invested more than $120 million into startups that The report defines digital biomarkers as "consumer-generated physiological and behavioral measures collected through connected digital tools that can be used to explain, influence and/or predict health-related outcomes", with an emphasis on the importance of "outcomes": data only becomes a biomarker when it has an impact.
So-called digital biomarkers could change the way healthcare providers and payers offer treatment and insurance to patients, according to a new report from top healthcare venture capital fund, Rock Health. The technology would allow insurers to incentivise their offerings, and design their policies around the data they receive. Elsewhere, hospitals could use digital biomarkers to identify individuals at the highest risk, and therefore the highest cost to the system. The report defines digital biomarkers as "consumer-generated physiological and behavioral measures collected through connected digital tools that can be used to explain, influence and/or predict health-related outcomes", with an emphasis on the importance of "outcomes": data only becomes a biomarker when it has an impact.